Funding Opportunities

Limited Submission Opportunities

(Applications through LSO office)

Intramural Funding Opportunities

  • Project Summary Deadline: June 8, 2021
    Emerson Collective Digital Oncology Care RFA

    The Emerson Collective invites grant applications for solutions that implement evidence-based research findings to improve patient health outcomes for clinical practice in oncology. Our goal is to offer funding that initiates new prototypes or new pilot studies of digital health solutions that engage patients with a team of care providers.
  • Deadline: June 16, 2021
    Emerson Collective Cancer Research Fund RFA

    The Emerson Collective Cancer Research Fund is requesting individual or team proposals for research projects. We encourage submission of 'high risk/high reward' initiatives.
  • Deadline: July 23, 2021
    HDFCCC Junior Cancer Researcher RFA
    Thanks to a generous donation, we are requesting applications from junior researchers who have an interest in working on high-risk high-reward projects in cancer. The donor intends the funding for individuals who want to apply novel approaches to solve major cancer-specific challenges, especially those with potential clinical impact.

Foundations/Other Sources

  • LOI Deadline: June 10, 2021
    The Honorable Tina Brozman Foundation for Ovarian Cancer Research Individual Investigator Awards

    Tina’s Wish awards annual grants to researchers proposing new ideas and concepts specifically for the early detection or prevention of ovarian cancer.
  • Deadline: June 21, 2021
    NCCN Pfizer Talazoparib Request for Proposals: Development of Talazoparib for Prostate Cancer

    National Comprehensive Cancer Network (NCCN) is pleased to announce a collaboration with Pfizer Global Medical Grants to offer a new grant opportunity seeking proposals to advance the understanding of the mechanisms of action, underlying biology, and clinical activity of talazoparib in prostate cancer.
  • Deadline: July 21, 2021
    Californians Linking Action with Science for Prevention of Breast Cancer (CLASP-BC): Phase 1 Convener

    A funding opportunity to advance the primary prevention of breast cancer by developing, disseminating, implementing, and evaluating high-impact population-based primary prevention interventions.
  • Pre-app Deadline: July 29, 2021
    Department of Defense Peer Reviewed Cancer Research Program Funding Opportunities
    • Behavioral Health Science Award
    • Career Development Award - Fellow Option    
    • Translational Team Science Award    
  • Deadline: rolling basis through Jan 31, 2022
    Partnership for Accelerating Cancer Therapies (PACT) Clinical Trials RFA 

    The Foundation for the NIH has issued an RFA for novel biomarkers to support the Partnership for Accelerating Cancer Therapies (PACT). The overall goal for this RFA is to solicit clinical trials to partner with the PACT initiative to provide biospecimens for exploratory deep immunoprofiling analysis, employing this standardized set of biomarker assays. The data from this immunoprofiling, along with the necessary de-identified clinical data from the trials, will be placed into the CIDC to continue to build a large body of standardized immunoprofiling data that can be used to validate existing biomarkers for clinical trial and regulatory use, and importantly, to develop new validated biomarkers for these purposes. Development and validation of these biomarkers will allow the immuno-oncology field to more accurately pair patients with novel immunotherapies being developed.

NIH Announcements

If you are a Cancer Center member who is interested in applying and receiving grant writing support, please contact Erin Bank.

To view all NCI funding opportunities, search here